313 related articles for article (PubMed ID: 23251626)
1. Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders.
Davidson DC; Hirschman MP; Sun A; Singh MV; Kasischke K; Maggirwar SB
PLoS One; 2012; 7(12):e51793. PubMed ID: 23251626
[TBL] [Abstract][Full Text] [Related]
2. Modeling HIV-1 Induced Neuroinflammation in Mice: Role of Platelets in Mediating Blood-Brain Barrier Dysfunction.
Jones LD; Jackson JW; Maggirwar SB
PLoS One; 2016; 11(3):e0151702. PubMed ID: 26986758
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid inhibits the release of soluble CD40L induced by non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus infected individuals.
Davidson DC; Schifitto G; Maggirwar SB
PLoS One; 2013; 8(3):e59950. PubMed ID: 23555843
[TBL] [Abstract][Full Text] [Related]
4. Differential Mechanisms of Inflammation and Endothelial Dysfunction by HIV-1 Subtype-B and Recombinant CRF02_AG Tat Proteins on Human Brain Microvascular Endothelial Cells: Implications for Viral Neuropathogenesis.
Bhargavan B; Kanmogne GD
Mol Neurobiol; 2018 Feb; 55(2):1352-1363. PubMed ID: 28127697
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individuals.
Davidson DC; Hirschman MP; Spinelli SL; Morrell CN; Schifitto G; Phipps RP; Maggirwar SB
J Immunol; 2011 Jan; 186(1):584-91. PubMed ID: 21115729
[TBL] [Abstract][Full Text] [Related]
6. Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis.
Ramirez SH; Fan S; Dykstra H; Reichenbach N; Del Valle L; Potula R; Phipps RP; Maggirwar SB; Persidsky Y
J Neurosci; 2010 Jul; 30(28):9454-64. PubMed ID: 20631174
[TBL] [Abstract][Full Text] [Related]
7. Tat 101-mediated enhancement of brain pericyte migration involves platelet-derived growth factor subunit B homodimer: implications for human immunodeficiency virus-associated neurocognitive disorders.
Niu F; Yao H; Zhang W; Sutliff RL; Buch S
J Neurosci; 2014 Aug; 34(35):11812-25. PubMed ID: 25164676
[TBL] [Abstract][Full Text] [Related]
8. Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder.
Gandhi N; Saiyed ZM; Napuri J; Samikkannu T; Reddy PV; Agudelo M; Khatavkar P; Saxena SK; Nair MP
J Neurovirol; 2010 Jul; 16(4):294-305. PubMed ID: 20624003
[TBL] [Abstract][Full Text] [Related]
9. Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia.
Sui Z; Sniderhan LF; Schifitto G; Phipps RP; Gelbard HA; Dewhurst S; Maggirwar SB
J Immunol; 2007 Mar; 178(5):3226-36. PubMed ID: 17312171
[TBL] [Abstract][Full Text] [Related]
10. Protective Effects of Ginsenoside Rb1 against Blood-Brain Barrier Damage Induced by Human Immunodeficiency Virus-1 Tat Protein and Methamphetamine in Sprague-Dawley Rats.
Li J; Zeng B; Hu X; Li Z; Zhang D; Yang G; Dai J; Zeng X
Am J Chin Med; 2018; 46(3):551-566. PubMed ID: 29690789
[TBL] [Abstract][Full Text] [Related]
11. HIV Tat-mediated induction of autophagy regulates the disruption of ZO-1 in brain endothelial cells.
Liao K; Niu F; Hu G; Guo ML; Sil S; Buch S
Tissue Barriers; 2020 Apr; 8(2):1748983. PubMed ID: 32299282
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction.
Woollard SM; Bhargavan B; Yu F; Kanmogne GD
J Cereb Blood Flow Metab; 2014 Jun; 34(6):1047-59. PubMed ID: 24667918
[TBL] [Abstract][Full Text] [Related]
13. Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?
Davidson DC; Jackson JW; Maggirwar SB
J Neuroinflammation; 2013 Dec; 10():144. PubMed ID: 24289660
[TBL] [Abstract][Full Text] [Related]
14. Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability.
Mahajan SD; Aalinkeel R; Sykes DE; Reynolds JL; Bindukumar B; Fernandez SF; Chawda R; Shanahan TC; Schwartz SA
J Clin Immunol; 2008 Sep; 28(5):528-41. PubMed ID: 18574677
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopenia.
Wang J; Zhang W; Nardi MA; Li Z
J Thromb Haemost; 2011 Mar; 9(3):562-73. PubMed ID: 21143381
[TBL] [Abstract][Full Text] [Related]
16. Disruption of blood-brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins.
Sun Y; Cai M; Liang Y; Zhang Y
J Neurovirol; 2023 Dec; 29(6):658-668. PubMed ID: 37899420
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain.
Pu H; Tian J; Flora G; Lee YW; Nath A; Hennig B; Toborek M
Mol Cell Neurosci; 2003 Sep; 24(1):224-37. PubMed ID: 14550782
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Tat protein increases the permeability of brain endothelial cells by both inhibiting occludin expression and cleaving occludin via matrix metalloproteinase-9.
Xu R; Feng X; Xie X; Zhang J; Wu D; Xu L
Brain Res; 2012 Feb; 1436():13-9. PubMed ID: 22197032
[TBL] [Abstract][Full Text] [Related]
19. The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin.
Natal C; Restituto P; Iñigo C; Colina I; Díez J; Varo N
J Clin Endocrinol Metab; 2008 Jun; 93(6):2319-27. PubMed ID: 18349065
[TBL] [Abstract][Full Text] [Related]
20. Peptide derived from HIV-1 TAT protein destabilizes a monolayer of endothelial cells in an in vitro model of the blood-brain barrier and allows permeation of high molecular weight proteins.
Cooper I; Sasson K; Teichberg VI; Schnaider-Beeri M; Fridkin M; Shechter Y
J Biol Chem; 2012 Dec; 287(53):44676-83. PubMed ID: 23150670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
